April 4, 2022
Research News Roundup — March 2022
By Advancing the Science contributor
March news reports are often focused on college basketball, daylight savings time and Mardi Gras. This year, Ukraine and the its people are top of mind for many, providing a sobering counterpoint. Behind the scenes, research has continued at Mayo Clinic, and several findings were released in March that help build the evidence and point […]
Tags: aging, Alzheimer's disease, animal model, artificial intelligence, biomarkers, chemotherapy, collaboration, COVID-19, depression, discovery research, drug discovery, genomics
November 12, 2021
American Medical Society for Sports Medicine position on regenerative medicine
The American Medical Society for Sports Medicine has released a position statement to guide responsible use of regenerative interventions when standard care doesn’t provide relief. The statement recommends key scientific and ethical considerations when prescribing regenerative medicine procedures. The position statement published in the Clinical Journal of Sport Medicine emphasizes safety, scientific validation, ethics and […]
Tags: arthritis, bioethics, Center for Regenerative Medicine, pain management, plasma, platelet rich plasma, Shane Shapiro, sports medicine, Zubin Master
January 25, 2021
Mayo Clinic Research in the news — 1/25/2021
From acupuncture, breast cancer, diabetes, euthyroid … all the way to Zika, Mayo Clinic research and experts are featured in the news. Also find COVID-19 observations, advice and findings. The Rochester Epidemiology Project: “The greatest medical resource you’ve never heard of” Rochester Magazine, 1/22/2021 The Rochester Epidemiology Project has changed the way we view ADHD. […]
Tags: acupuncture, acute flaccid myelitis, ADHD, Alzheimer's disease, amyloidosis, artificial intelligence, biomarkers, breast cancer, Brent Bauer, cancer, cancer genomics, cannabidiol (CBD)
January 5, 2021
Looking back on 2020: A successful year of research at Mayo Clinic in Florida
By Advancing the Science contributor
At Mayo Clinic, Research and Education provide the basis for all we are able to do for patients today. Furthermore, they enable practice transformation as we seek to meet future patient needs. From new capabilities in cell therapy and immunotherapy, to advances in neurodegenerative diseases and studies of the virus that causes COVID-19, research at Mayo Clinic continued […]
Tags: Alzheimer's disease, Ben Pollock, biomanufacturing, biomarkers, biostatistics, brain, cancer, CAR-T cell therapy, carbon ion therapy, Center for Regenerative Medicine, chemotherapy, clinical research
October 2, 2020
Mayo Clinic Research in the news — 10/2/2020
This week Mayo Clinic Research and researchers have been noted in stories on older women’s sexuality, the opioid crisis, some health benefits of coffee, using Alexa for COVID-19, and a range of other topics. Read on for links and brief excerpts from news outlets around the country. Laughter May Be Effective Medicine for These Trying […]
Tags: Amir Lerman, artificial intelligence, B-cell disorders, biomarkers, C. diff, cancer, cardiology, colon cancer, COVID-19, diabetes, dogs, emergency medicine
September 25, 2020
Mayo Clinic Research in the news — 9/25/2020
COVID-19 still is holding a spot in the headlines, and probably will for at least the next year or so. But more and more there is re-emerging interest in other health care research. In this post, you’ll find Mayo Clinic Research and research experts cited on Alzheimer’s, opioids, artificial intelligence and physician burnout, seafood and […]
Tags: Andrew Badley, artificial intelligence, big data, bile duct cancer, Bobbie Gostout, brain, cancer, cardiology, cardiovascular disease, cholangiocarcinoma, clinical research, clinical trials
September 18, 2020
Mayo Clinic Research in the news — 9/18/2020
Allure Magazine, KAAL-TV, The Scientist and Yahoo! are just a few of the outlets that were talking this week with Mayo Clinic researchers and about Mayo Clinic Research. Read on for national and international news on COVID-19, cancer, disparities in health care access and outcomes, the relationship between migraine and pregnancy, vaping and more. Coffee […]
Tags: Andrew Rule, cardiology, Charles Loprinzi, chemotherapy, Christopher Mackintosh, colorectal cancer, COVID-19, Dawn Davis, Gregory Poland, health disparities, hormones, influenza
August 28, 2020
Mayo Clinic Research in the news — COVID, COVID, COVID
There has been a lot of discussion surrounding convalescent plasma in the last week. A few articles are listed here, an internet search will give you dozens more. In addition to convalescent plasma, our researchers are working on tests, vaccines, social and population health issues relating to COVID-19. Recent news articles highlighting Mayo Clinic Research […]
Tags: Angela Mattke, cardiology, COVID-19, emergency department, genomics, Gregory Poland, health disparities, immunization, infection control, infectious disease, LaPrincess Brewer, Michael Ackerman
August 21, 2020
Mayo Clinic Research in the news — 8/21/2020
A wide range of Mayo Clinic expertise was highlighted in the past week, with local, national and international media outlets quoting researchers and referring to Mayo Clinic research findings. Following are a selection of these news articles, with a brief excerpt and link to the full story on the appropriate websites. For ease of review, […]
Tags: Alzheimer's disease, Andrew Badley, blood pressure, Bobbi Pritt, Brian Mohney, cardiology, Centers for Disease Control and Prevention, COVID-19, diabetes, emergency department, epidemiology, genetics
August 14, 2020
Mayo Clinic Research in the news 8/14/2020
While much of the news around health care research is COVID-19 related, Mayo Clinic researchers are hard at work across the entire spectrum of health and health care delivery. Our multidisciplinary research teams are seeking ways to improve outcomes, lower costs and enhance the experience of patients, providers and caregivers. Read on for snippets of […]
Tags: aging, Andrew Badley, antibodies, breast cancer, chemotherapy, Clifford Jack Jr., clinical research, clinical trials, COVID-19, Devon Rubin, Eugenia Trushina, Grzegorz Nowakowski